Should You Buy the SpaceX IPO? Here's What Jim Cramer Thinks

SpaceX is reportedly targeting an IPO valuation of $1.75 trillion to $2 trillion, with Jim Cramer warning the stock could be driven to as much as $6 trillion if a very small float meets intense demand. The article argues the main risks are scarcity-driven price discovery, lock-up expiration supply overhang, and potential crowding-out effects from other mega-tech IPOs. While SpaceX has real revenue from rocketry and Starlink, the piece urges investors to wait for post-IPO froth to settle before buying.

Analysis

The real tradeable issue here is not whether SpaceX deserves a large private-market mark, but whether an artificially tiny public float creates a temporary scarcity premium that leaks into the rest of growth equities. If the IPO is staged for spectacle rather than price discovery, the first-order winners are the banks/VC holders monetizing optionality; the second-order losers are other late-stage private names that will be marked off the same frothy comp set and forced to clear at richer discount rates, especially in software/AI where exit math already depends on long-duration assumptions.

The broader market risk is flow-driven, not fundamentals-driven, and that matters over the next 1-3 months. A marquee IPO can siphon marginal dollars from passive and active growth sleeves, creating a temporary underperformance pocket in megacap tech and adjacent winners as investors fund allocations by trimming existing positions. That effect is usually strongest when the issue is oversubscribed and lock-up dates are visible on the calendar; the reversal often comes 90-180 days later when supply normalizes and the market is left with less narrative and more dilution.

The contrarian point is that the hype may actually compress future returns for the issuer rather than extend them: a huge opening pop sets an unrealistic reference price, making every subsequent quarter look like a disappointment unless execution beats impossible expectations. For semis, the indirect read-through is mildly negative for NVDA and neutral-to-negative for INTC; neither is a direct competitor, but both sit in the same “AI frontier” basket that could face valuation crowding if new capital rotates into private-space and AI listings. The better setup is to fade the event-driven enthusiasm after the first few sessions rather than front-run the IPO itself.

Key Decisions for Investors

• Avoid chasing the first 1-3 days of any SpaceX IPO; wait for post-debut price discovery and look for a 15-25% retracement before considering risk.
• Use a tactical hedge: short a basket of high-beta growth proxies against long cash if IPO demand broadens into a funding-rally in equities over the next 2-6 weeks.
• For NVDA, maintain exposure but trim into any post-IPO multiple expansion driven by scarcity sentiment; the risk/reward is worse if speculative capital rotates from listed AI into private AI/spaces.
• For INTC, no direct catalyst, but any “frontier-tech” rerating helps sentiment less than fundamentals; avoid using the IPO as a reason to add until the market proves real capex demand.